In English | En español
Questions About Cancer? 1-800-4-CANCER

Cancer Genetics Risk Assessment and Counseling (PDQ®)

  • Updated: 09/30/2014

Table 1. Clinical Utility of Genetic/Genomic Testsa

Test Ordered By Clinical Utility Accepted Clinical Utility Uncertain  
aAdapted from Robson et al.[2]
Health care ProfessionalHigh-penetrance gene mutations (i.e., BRCA1, BRCA2)Low- and moderate-penetrance gene mutations (e.g., CHEK2)
ConsumerHigh-penetrance gene mutations (i.e., BRCA1, BRCA2)Low- and moderate-penetrance gene mutations

References

  1. Robson ME, Storm CD, Weitzel J, et al.: American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility. J Clin Oncol 28 (5): 893-901, 2010.  [PUBMED Abstract]